Breaking News Instant updates and real-time market news.

ROAN

Roan Resources

$1.16

-0.23 (-16.55%)

08:06
06/14/19
06/14
08:06
06/14/19
08:06

Roan Resources sees Q2 production over 50,000 mboepd

Sees Q2 capital expenditures below $155M. The company anticipates 14 gross operated wells to be turned to first sales during June and July. These wells are spaced and being completed in accordance with the company's improved development program of 2019 and anticipates strong performance results from the Mad Play unit, along with the Mayes wells .

ROAN Roan Resources
$1.16

-0.23 (-16.55%)

10/11/18
STFL
10/11/18
INITIATION
Target $25
STFL
Buy
Roan Resources initiated with a Buy at Stifel
Stifel analyst Derrick Whitfield initiated Roan Resources with a Buy rating and a $25 price target, calling it an "under-followed stock in an oversold basin." Roan has "Permian-quality assets that trade at a non-Permian valuation" given the broad overhang currently over Anadarko stocks, Whitfield tells investors.
04/04/19
IMPC
04/04/19
INITIATION
Target $10
IMPC
Outperform
Roan Resources initiated with an Outperform at Imperial Capital
Imperial Capital analyst Irene Haas started Roan Resources with an Outperform rating and $10 price target. The company stands out as one of the more successful small cap producers in the Anadarko Basin, Haas tells investors in a research note. She believes the company is "differentiated from its peers in superior technical competency and reliable execution."
05/16/19
IMPC
05/16/19
DOWNGRADE
Target $6
IMPC
In-Line
Roan Resources downgraded to In-Line from Outperform at Imperial Capital
Imperial Capital analyst Irene Haas downgraded Roan Resources to In-Line from Outperform and lowered her price target for the shares to $6 from $10. The company's Q1 earnings missed expectations due to well performance, ethane rejection, and weak NGL prices, Haas tells investors in a research note. The analyst's downgrade reflects liquidity concerns, Roan's high NGL production mix, and uncertainty related to potential strategic alternatives.
05/16/19
05/16/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Occidental Petroleum (OXY) downgraded to Hold from Buy at Argus with analyst Bill Selesky citing its confirmed purchase of Anadarko Petroleum (APC) for $76 per share and saying the company is overpaying for the assets with a bid well above that of Chevron's (CVX) $65 per share offer. 2. Nomura (NMR) downgraded to Sell from Neutral at Citi with analyst Koichi Niwa saying he sees a "grim" earnings environment for Nomura's domestic retail division and fixed income business. 3. Sito Mobile (SITO) downgraded to Hold from Buy at Lake Street with analyst Mark Argento citing the company's "big" Q1 miss and said he sees uncertainty around Sito Mobile's new product strategy and liquidity concerns in the near term. 4. The Stars Group (TSG) downgraded to Hold from Buy at Desjardins. 5. Roan Resources (ROAN) downgraded to In-Line from Outperform at Imperial Capital with analyst Irene Haas saying the company's Q1 earnings missed expectations due to well performance, ethane rejection, and weak NGL prices. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

EVOK

Evoke Pharma

$0.53

-0.0325 (-5.74%)

08:32
06/27/19
06/27
08:32
06/27/19
08:32
Hot Stocks
Evoke Pharma request Type A FDA meeting for resubmission of Gimoti NDA »

Evoke Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCS

OncoSec

$2.50

-0.11 (-4.21%)

08:32
06/27/19
06/27
08:32
06/27/19
08:32
Hot Stocks
OncoSec enters collaboration with Dana-Farber Cancer Institute »

OncoSec Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESPR

Esperion

$48.64

-0.36 (-0.73%)

08:31
06/27/19
06/27
08:31
06/27/19
08:31
Recommendations
Esperion analyst commentary  »

Esperion funding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SQBG

Sequential Brands

$0.50

-0.0049 (-0.98%)

08:30
06/27/19
06/27
08:30
06/27/19
08:30
Hot Stocks
NBA player Montrezl Harrell signs multi-year sneaker, apparel deal with AND1 »

AND1 and its newest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APEX

Apex Global Brands

$0.60

0.0999 (19.98%)

, ARVN

Arvinas

$23.38

0.93 (4.14%)

08:30
06/27/19
06/27
08:30
06/27/19
08:30
Options
Four new option listings and one option delisting on June 27th »

New option listings for…

APEX

Apex Global Brands

$0.60

0.0999 (19.98%)

ARVN

Arvinas

$23.38

0.93 (4.14%)

LOVE

Lovesac

$28.99

-0.83 (-2.78%)

PRVB

Provention Bio

$11.41

-0.805 (-6.59%)

CHKE

Cherokee

$0.60

0.0999 (19.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APTV

Aptiv

$78.87

0.72 (0.92%)

08:29
06/27/19
06/27
08:29
06/27/19
08:29
Initiation
Aptiv initiated  »

Credit Suisse bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GEMP

Gemphire Therapeutics

$0.94

-0.26 (-21.67%)

08:28
06/27/19
06/27
08:28
06/27/19
08:28
Upgrade
Gemphire Therapeutics rating change  »

Gemphire Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESPR

Esperion

$48.64

-0.36 (-0.73%)

08:27
06/27/19
06/27
08:27
06/27/19
08:27
Hot Stocks
Esperion reaches $200M revenue-based funding agreement with Oberland Capital »

Esperion and an investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDNA

CareDx

$34.68

-0.99 (-2.78%)

08:27
06/27/19
06/27
08:27
06/27/19
08:27
Hot Stocks
CareDx 'applauds' progress in Medicare immunosuppressive medication legislation »

CareDx said it,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAN

Dana

$18.38

0.74 (4.20%)

08:27
06/27/19
06/27
08:27
06/27/19
08:27
Initiation
Dana initiated  »

Credit Suisse bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$57.00

-1.01 (-1.74%)

08:26
06/27/19
06/27
08:26
06/27/19
08:26
Periodicals
Huawei in talks with Verizon over royalty payments for patents, CNBC reports »

Huawei is in discussions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 09

    Jul

  • 01

    Aug

DOVA

Dova Pharmaceuticals

$10.56

0.27 (2.62%)

08:25
06/27/19
06/27
08:25
06/27/19
08:25
Hot Stocks
Dova Pharmaceuticals announces FDA approval of sNDA for DOPTELET »

Dova Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 30

    Jun

WBC

Wabco

$131.95

-0.23 (-0.17%)

08:25
06/27/19
06/27
08:25
06/27/19
08:25
Conference/Events
Wabco to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

TSLA

Tesla

$219.22

-0.47 (-0.21%)

08:24
06/27/19
06/27
08:24
06/27/19
08:24
Initiation
Tesla initiated  »

Tesla initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OVID

Ovid Therapeutics

$1.79

-0.04 (-2.19%)

08:23
06/27/19
06/27
08:23
06/27/19
08:23
Hot Stocks
Ovid Therapeutics initiates Phase 3 trial of OV101 »

Ovid Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KTOS

Kratos Defense

$22.20

0.35 (1.60%)

08:22
06/27/19
06/27
08:22
06/27/19
08:22
Hot Stocks
Kratos Defense receives $4.1M C5ISR system contract award »

Kratos Defense &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRCA

Verrica Pharmaceuticals

08:22
06/27/19
06/27
08:22
06/27/19
08:22
Recommendations
Verrica Pharmaceuticals analyst commentary  »

Verrica reported positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLPH

Delphi Technologies

$19.23

0.67 (3.61%)

08:21
06/27/19
06/27
08:21
06/27/19
08:21
Initiation
Delphi Technologies initiated  »

Credit Suisse sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETTX

Entasis Therapeutics

$6.23

0.04 (0.65%)

08:21
06/27/19
06/27
08:21
06/27/19
08:21
Hot Stocks
Entasis Therapeutics announces new results on antimicrobial programs »

Entasis Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:20
06/27/19
06/27
08:20
06/27/19
08:20
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

$0.00

(0.00%)

08:20
06/27/19
06/27
08:20
06/27/19
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:20
06/27/19
06/27
08:20
06/27/19
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$183.53

1.54 (0.85%)

08:20
06/27/19
06/27
08:20
06/27/19
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$77.84

0.82 (1.06%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$63.46

0.99 (1.58%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.